
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B604925FC9933AB6040049246AB3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ckj">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Clinical Kidney Journal">
<meta name="citation_title" content="Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients">
<meta name="citation_author" content="Justine Solignac">
<meta name="citation_author_institution" content="Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author" content="Emilien Delmont">
<meta name="citation_author_institution" content="Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author" content="Etienne Fortanier">
<meta name="citation_author_institution" content="Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author" content="Shahram Attarian">
<meta name="citation_author_institution" content="Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author" content="Julien Mancini">
<meta name="citation_author_institution" content="SESSTIM, INSERM Université Aix Marseille, Sciences Economiques et Sociales de la Santé and Traitement de l&#x27;Information Médicale, Marseille, France">
<meta name="citation_author" content="Laurent Daniel">
<meta name="citation_author_institution" content="Service d&#x27;Anatomo-cyto-pathologie, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author" content="Ioana Ion">
<meta name="citation_author_institution" content="Service de Neurologie Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France">
<meta name="citation_author" content="Jean-Etienne Ricci">
<meta name="citation_author_institution" content="Service de Cardiologie, Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France">
<meta name="citation_author" content="Thomas Robert">
<meta name="citation_author_institution" content="Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author_institution" content="MMG, Bioinformatics and Genetics, Aix-Marseille Université, Marseille, France">
<meta name="citation_author" content="Gilbert Habib">
<meta name="citation_author_institution" content="Service de Cardiologie, Insuffisance Cardiaque, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_author" content="Olivier Moranne">
<meta name="citation_author_institution" content="Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Nîmes, France">
<meta name="citation_author_institution" content="IDESP, INSERM Université de Montpellier, Montpellier, France">
<meta name="citation_author" content="Noémie Jourde-Chiche">
<meta name="citation_author_institution" content="Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France">
<meta name="citation_publication_date" content="2022 May 5">
<meta name="citation_volume" content="15">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="1747">
<meta name="citation_doi" content="10.1093/ckj/sfac118">
<meta name="citation_pmid" content="36003663">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/pdf/sfac118.pdf">
<meta name="description" content="Hereditary transthyretin amyloidosis (ATTRv) is a disabling and life-threatening disease that primarily affects the nervous system and heart. Its kidney involvement has not been systematically studied, particularly in non-V30M mutations, and is not ...">
<meta name="og:title" content="Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Hereditary transthyretin amyloidosis (ATTRv) is a disabling and life-threatening disease that primarily affects the nervous system and heart. Its kidney involvement has not been systematically studied, particularly in non-V30M mutations, and is not ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="9394715">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1093/ckj/sfac118"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/sfac118.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9394715%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/9394715/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/9394715/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ckj.png" alt="Clinical Kidney Journal logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Clinical Kidney Journal" title="Link to Clinical Kidney Journal" shape="default" href="http://ckj.oxfordjournals.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Clin Kidney J</button></div>. 2022 May 5;15(9):1747–1754. doi: <a href="https://doi.org/10.1093/ckj/sfac118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1093/ckj/sfac118</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Clin%20Kidney%20J%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clin%20Kidney%20J%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Clin%20Kidney%20J%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Clin%20Kidney%20J%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patients</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Solignac%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Justine Solignac</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Justine Solignac</span></h3>
<div class="p">
<sup>1</sup>
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Solignac%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Justine Solignac</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delmont%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Emilien Delmont</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Emilien Delmont</span></h3>
<div class="p">
<sup>2</sup>
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delmont%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Emilien Delmont</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fortanier%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Etienne Fortanier</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Etienne Fortanier</span></h3>
<div class="p">
<sup>3</sup>
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fortanier%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Etienne Fortanier</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Attarian%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Shahram Attarian</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Shahram Attarian</span></h3>
<div class="p">
<sup>4</sup>
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Attarian%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shahram Attarian</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mancini%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Julien Mancini</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Julien Mancini</span></h3>
<div class="p">
<sup>5</sup>
SESSTIM, INSERM Université Aix Marseille, Sciences Economiques et Sociales de la Santé and Traitement de l'Information Médicale, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mancini%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Julien Mancini</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Daniel%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Laurent Daniel</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Laurent Daniel</span></h3>
<div class="p">
<sup>6</sup>
Service d'Anatomo-cyto-pathologie, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Daniel%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laurent Daniel</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ion%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Ioana Ion</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Ioana Ion</span></h3>
<div class="p">
<sup>7</sup>
Service de Neurologie Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ion%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ioana Ion</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ricci%20JE%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jean-Etienne Ricci</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jean-Etienne Ricci</span></h3>
<div class="p">
<sup>8</sup>
Service de Cardiologie, Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ricci%20JE%22%5BAuthor%5D" class="usa-link"><span class="name western">Jean-Etienne Ricci</span></a>
</div>
</div>
<sup>8</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Robert%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Thomas Robert</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Thomas Robert</span></h3>
<div class="p">
<sup>9</sup>
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">
<sup>10</sup>
MMG, Bioinformatics and Genetics, Aix-Marseille Université, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Robert%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Thomas Robert</span></a>
</div>
</div>
<sup>9,</sup><sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Habib%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Gilbert Habib</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Gilbert Habib</span></h3>
<div class="p">
<sup>11</sup>
Service de Cardiologie, Insuffisance Cardiaque, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Habib%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gilbert Habib</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moranne%20O%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Olivier Moranne</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Olivier Moranne</span></h3>
<div class="p">
<sup>12</sup>
Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Nîmes, France</div>
<div class="p">
<sup>13</sup>
IDESP, INSERM Université de Montpellier, Montpellier, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moranne%20O%22%5BAuthor%5D" class="usa-link"><span class="name western">Olivier Moranne</span></a>
</div>
</div>
<sup>12,</sup><sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jourde-Chiche%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Noémie Jourde-Chiche</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Noémie Jourde-Chiche</span></h3>
<div class="p">
<sup>14</sup>
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jourde-Chiche%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Noémie Jourde-Chiche</span></a>
</div>
</div>
<sup>14</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff2">
<sup>2</sup>
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff3">
<sup>3</sup>
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff4">
<sup>4</sup>
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff5">
<sup>5</sup>
SESSTIM, INSERM Université Aix Marseille, Sciences Economiques et Sociales de la Santé and Traitement de l'Information Médicale, Marseille, France</div>
<div id="aff6">
<sup>6</sup>
Service d'Anatomo-cyto-pathologie, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff7">
<sup>7</sup>
Service de Neurologie Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France</div>
<div id="aff8">
<sup>8</sup>
Service de Cardiologie, Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France</div>
<div id="aff9">
<sup>9</sup>
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff10">
<sup>10</sup>
MMG, Bioinformatics and Genetics, Aix-Marseille Université, Marseille, France</div>
<div id="aff11">
<sup>11</sup>
Service de Cardiologie, Insuffisance Cardiaque, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div id="aff12">
<sup>12</sup>
Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Nîmes, France</div>
<div id="aff13">
<sup>13</sup>
IDESP, INSERM Université de Montpellier, Montpellier, France</div>
<div id="aff14">
<sup>14</sup>
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France</div>
<div class="author-notes p"><div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Correspondence to: Justine Solignac; E-mail: <span>justine.solignac@ap-hm.fr</span></p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2022 Jan 10; Collection date 2022 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2022. Published by Oxford University Press on behalf of the ERA.</div>
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by-nc/4.0/</a>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <span>journals.permissions@oup.com</span></p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC9394715  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36003663/" class="usa-link">36003663</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="abs1"><h3 class="pmc_sec_title">Background</h3>
<p>Hereditary transthyretin amyloidosis (ATTRv) is a disabling and life-threatening disease that primarily affects the nervous system and heart. Its kidney involvement has not been systematically studied, particularly in non-V30M mutations, and is not well known to nephrologists.</p></section><section id="abs2"><h3 class="pmc_sec_title">Methods</h3>
<p>We conducted a retrospective study describing the kidney phenotype of all prevalent patients with ATTR mutations, with neurological or cardiac involvement or presymptomatic carriers, followed up in two university hospitals from the South of France between June 2011 and June 2021.</p></section><section id="abs3"><h3 class="pmc_sec_title">Results</h3>
<p>A total of 103 patients were included, among whom 79 were symptomatic and 24 were presymptomatic carriers. Patients carried 21 different ATTR mutations and 54% carried the V30M mutation. After a mean follow-up of 7.9 ± 25.7 years, 30.4% of the symptomatic patients had developed chronic kidney disease (CKD) and 20.3% had a urinary protein:creatinine ratio ≥0.5 g/g. None of the presymptomatic carriers had CKD or proteinuria. In a multivariate analysis, late onset of symptoms (after 60 years), the V122I mutation and proteinuria were significantly associated with CKD. The median CKD-free survival in symptomatic patients was estimated at 81.0 years (interquartile range 77.1–84.9). It did not differ between V30M and non-V30M patients, but was lower in patients with the V122I mutation. The average age of the onset of CKD was 69.3 ± 13.0 years. In one 38-year-old V30M female who presented a kidney-predominant phenotype, treatment with patisiran resulted in remission of the nephrotic syndrome.</p></section><section id="abs4"><h3 class="pmc_sec_title">Conclusion</h3>
<p>CKD affects almost one-third of patients with symptomatic ATTRv. The role of ATTRv per se in the development of CKD in this population remains to be determined, but some patients may benefit from specific therapies.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> ATTR, chronic kidney disease, hereditary transthyretin amyloidosis, kidney amyloidosis, proteinuria</p></section></section><section id="sec1"><h2 class="pmc_sec_title">INTRODUCTION</h2>
<p>Hereditary transthyretin amyloidosis (ATTRv) is a systemic autosomal dominant genetic disease. Transthyretin (TTR), also called prealbumin, is one of the most abundant circulating proteins; 90% of TTR is synthesized by the liver. More than 120 mutations in the <em>TTR</em> gene have been described, of which at least 15 are associated with documented kidney involvement [<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a>]. TTR mutations result in a decrease in the interactions between the four subunits of the protein tetramer. Monomers aggregate into amyloid fibrils that deposit in tissues and impair their functions [<a href="#bib2" class="usa-link" aria-describedby="bib2">2</a>].</p>
<p>It should be pointed out that wild-type TTR can also cause amyloidosis, called ‘senile ATTR amyloidosis’, with predominantly cardiac involvement in elderly subjects, related to the deposition of fibrils derived from unmutated TTR.</p>
<p>ATTRv has variable penetrance and expressivity and usually becomes symptomatic in adulthood, with heterogeneity in the clinical presentation and clinical course. This phenotypic variability often leads to diagnostic difficulty or delay, especially in countries where the disease is not considered endemic. The main clinical manifestation is a rapidly progressive sensorimotor and autonomic polyneuropathy. Other manifestations are cardiac, cerebral, ocular, gastrointestinal and renal [<a href="#bib3" class="usa-link" aria-describedby="bib3">3</a>].</p>
<p>Worldwide, the prevalence of the disease is estimated at 0.56–1 per 10<sup>6</sup> inhabitants, with a higher prevalence in Portugal, Sweden and Japan, where patients most often carry the V30M mutation (substitution of a valine by a methionine at position 30) [<a href="#bib4" class="usa-link" aria-describedby="bib4">4</a>, <a href="#bib5" class="usa-link" aria-describedby="bib5">5</a>].</p>
<p>Although rare, ATTRv is a disabling and life-threatening disease and early diagnosis is crucial. Survival from amyloid disease onset has been estimated in the literature at 7–12 years [<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>]. The last decade has seen the development of effective, innovative therapies. Liver transplantation, which was the first-line treatment, is now being largely replaced by less invasive treatments such as the tetramer stabilizer tafamidis or the gene silencing molecules patisiran and inotersen [<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>]. A promising therapy using CRISPR-Cas9 <em>in vivo</em> hepatic gene editing is also under development [<a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>]. There are no specific data on kidney outcomes in patients with kidney amyloidosis under gene silencing therapies.</p>
<p>Kidney involvement of ATTRv is not well known and has been poorly studied. A large Portuguese cohort described proteinuria in one-third of patients and end-stage kidney disease (ESKD) in 11% [<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a>]. However, these data only concern patients with the V30M mutation the main mutation encountered in Portugal. In France, due to a more important intermingling of the population, the mutations are more diverse [<a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>, <a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>]. Patients with a <em>TTR</em> gene mutation other than V30M may actually present kidney involvement [<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a>, <a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>], and they are still under represented in the literature.</p>
<p>Our main objective was to study chronic kidney disease (CKD) and proteinuria prevalence in a French retrospective cohort of patients with <em>TTR</em> mutations, symptomatic or not, followed up in the Neurology, Cardiology and Nephrology Departments in the university hospitals of Marseille and Nîmes in the South of France.</p></section><section id="sec2"><h2 class="pmc_sec_title">MATERIALS AND METHODS</h2>
<section id="sec2-1"><h3 class="pmc_sec_title">Design of the study</h3>
<p>This is a retrospective cohort study. The inclusion period was from 1 June 2011 to 1 June 2021.</p></section><section id="sec2-2"><h3 class="pmc_sec_title">Study population</h3>
<p>We included all prevalent patients carrying a mutation causing ATTRv, symptomatic or not, followed up in the Neurology, Cardiology and Nephrology Departments in the university hospitals of Marseille and Nîmes.</p>
<p>The data included in this study were anonymized, approved by the local ethics committee and registered at the Health Data Portal of Assistance Publique–Hôpitaux de Marseille (PADS 21-038).</p></section><section id="sec2-3"><h3 class="pmc_sec_title">Objectives</h3>
<p>Our primary objective was to evaluate the prevalence of CKD and proteinuria in patients with a <em>TTR</em> mutation. Our secondary objectives were to study the survival without CKD, from birth to the last follow-up, in patients with a <em>TTR</em> mutation and to describe factors associated with CKD in this population.</p></section><section id="sec2-4"><h3 class="pmc_sec_title">Definitions</h3>
<p>Estimated glomerular filtration rate (eGFR) was calculated with the 2021 Chronic Kidney Disease Epidemiology Collaboration formula [<a href="#bib14" class="usa-link" aria-describedby="bib14">14</a>]. CKD was defined as an eGFR &lt;60 mL/min/1.73 m<sup>2</sup> confirmed after 3 months. The presence of significant proteinuria was defined by a urinary protein:creatinine ratio (UPCR) ≥0.5 g/g.</p>
<p>Neurological involvement of ATTRv was defined by the presence of clinical symptoms of neuropathy (dysesthesias, carpal tunnel syndrom, motor deficits) associated with an impairment of electrochemical skin conductance evaluated by Sudoscan (Impeto Medical, Paris, France) or electromyogram (EMG). The severity of the neuropathy was assessed through the functional score of polyneuropathy disability (PND), representing walking capacity [<a href="#bib15" class="usa-link" aria-describedby="bib15">15</a>].</p>
<p>Cardiac involvement of ATTRv was defined by the presence of characteristic features of myocardial amyloid infiltration on transthoracic echocardiography (TTE) or on magnetic resonance imaging (MRI).</p>
<p>Patients were defined as symptomatic if they carried an ATTRv mutation and were symptomatic. Amyloid disease onset was defined as the beginning of symptoms, which could be, in addition to neurological and cardiac involvement, weight loss, fatigue, gastrointestinal disorders or ocular manifestations.</p>
<p>Patients were defined as presymptomatic if they carried an ATTRv mutation and were not symptomatic, with no neurological or cardiac involvement.</p>
<p>We defined high blood pressure (BP) as &gt;140/90 mmHg.</p></section><section id="sec2-5"><h3 class="pmc_sec_title">
<em>TTR</em> gene analyses</h3>
<p>All patients gave their informed consent to genetic studies prior to this study. Direct Sanger sequencing of the <em>TTR</em> gene’s full coding region was performed on DNA from mononuclear blood cells. Only <em>TTR</em> mutations known to be responsible for ATTRv according to the Human Gene Database and <a href="http://www.amyloidosismutations.com/mut-attr.php" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.amyloidosismutations.com/mut-attr.php</a> were considered in this work.</p></section><section id="sec2-6"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Categorical values were expressed as number (percentage) and quantitative values were expressed as mean ± standard deviation (SD).</p>
<p>Patients’ characteristics were reported as a descriptive cross-sectional analysis at the last assessment during the follow-up. Factors associated with CKD were identified using odds ratio (OR) calculations with Fisher's exact test, followed by a multivariate analysis with a logistic regression model.</p>
<p>CKD-free survival was determined by the Kaplan–Meier method. Comparison of the CKD-free survival according to <em>TTR</em> mutations was performed with the logrank test.</p></section></section><section id="sec3"><h2 class="pmc_sec_title">RESULTS</h2>
<section id="sec3-1"><h3 class="pmc_sec_title">Population</h3>
<p>Overall, 103 patients were included in the analysis, of whom 79 had symptomatic ATTRv and 24 were presymptomatic <em>TTR</em> mutation carriers. The main characteristics of the population are shown in Table <a href="#tbl1" class="usa-link">1</a>. The majority of patients were male (64.1%). The mean age at the last assessment was 64.0 ± 15.1 years. Patients carried 21 different ATTR mutations and 54% carried the V30M mutation. In the 79 patients with symptomatic ATTRv amyloidosis, the male:female ratio was 2.1:1 (1.6:1 in V30M patients and 2.3:1 in patients with a <em>TTR</em> gene mutation other than V30M). A total of 58 (73.4%) had predominant neurological involvement and 21 (26.6%) had predominant cardiac involvement at diagnosis. At the time of their last assessment, 72 (91.1%) patients had neurological involvement and 26 (32.9%) had cardiac involvement. The different organ involvements of V30M and V122I patients are summarized in the <a href="#sup1" class="usa-link">Supplementary data, Table S1</a>. A total of 50 (63.3%) patients received first-line treatment with tafamidis, 11 (13.9%) received first-line treatment with patisiran or inotersen and 6 (7.6%) were liver transplant recipients. The mean follow-up since diagnosis was 7.9 ± 25.7 years. During the follow-up, 12 patients died, at a mean age of 73.6 ± 11.1 years.</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Patients’ characteristics</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" rowspan="1" colspan="1">Parameters</th>
<th align="left" rowspan="1" colspan="1">Symptomatic patients (<em>n</em> = 79)</th>
<th align="left" rowspan="1" colspan="1">presymptomatic carriers (<em>n</em> = 24)</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Gender ratio (male:female)</td>
<td rowspan="1" colspan="1">2.1:1</td>
<td rowspan="1" colspan="1">1:1</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Mutation V30M, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">42 (53.2)</td>
<td rowspan="1" colspan="1">14 (58.3)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Other mutations, <em>n</em> (%)<br>V122I<br>F64L<br>S77Y<br>E89Q<br>Other</td>
<td rowspan="1" colspan="1">37 (46.9)<br>8 (10.1)<br>4 (5.1)<br>3 (3.8)<br>3 (3.8)<br>14 (17.7)</td>
<td rowspan="1" colspan="1">10 (41.7)<br>0 (0)<br>4 (16.7)<br>1 (4.2)<br>2 (8.3)<br>3 (12.5)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Type 2 diabetes, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">6 (7.6)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">High BP, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">23 (29.1)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Body mass index, mean ± SD</td>
<td rowspan="1" colspan="1">24.5 ± 4.6</td>
<td rowspan="1" colspan="1">24.8 ± 4.8</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age at the onset of symptoms, mean ± SD</td>
<td rowspan="1" colspan="1">58.1 ± 16.5</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr><td colspan="3" align="center" rowspan="1">At the diagnosis of ATTR amyloidosis</td></tr>
<tr>
<td rowspan="1" colspan="1">Neuropathy, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">58 (73.4)</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Cardiac amyloidosis, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">35 (44.3)</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD (eGFR &lt;60 mL/min/1.73 m²), <em>n</em> (%)</td>
<td rowspan="1" colspan="1">13 (16.5)</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Proteinuria (UPCR ≥0.5 g/g), <em>n</em> (%)</td>
<td rowspan="1" colspan="1">9/54 (16.1)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr><td colspan="3" align="center" rowspan="1">At The Last Assesment</td></tr>
<tr>
<td rowspan="1" colspan="1">Age (years), mean ± SD</td>
<td rowspan="1" colspan="1">64.0 ± 15.1</td>
<td rowspan="1" colspan="1">43.8 ± 12.9</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Neurological involvement, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">72 (91.1)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Cardiac involvement, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">43 (54.4)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Elevated level of BNP or NT-proBNP, <em>n</em> (%)<br>With cardiac involvement<br>Without cardiac involvement</td>
<td rowspan="1" colspan="1">24/73 (32.9)<br>23 (55.8)<br>1/30 (3.3)</td>
<td rowspan="1" colspan="1">0/18 (0)<br>0/18 (0)<br>0/18 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Elevated level of troponin I or troponin T hs, <em>n</em> (%)<br>With cardiac involvement<br>Without cardiac involvement</td>
<td rowspan="1" colspan="1">37/73 (50.7)<br>33 (76.7)<br>4/30 (13.3)</td>
<td rowspan="1" colspan="1">0/15 (0)<br>0/15 (0)<br>0/15 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Proteinuria (UPCR ≥0.5 g/g), <em>n</em> (%)</td>
<td rowspan="1" colspan="1">12/59 (20.3)</td>
<td rowspan="1" colspan="1">0/16 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD KDIGO 1</td>
<td rowspan="1" colspan="1">2/59 (3.3)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD KDIGO 2</td>
<td rowspan="1" colspan="1">1/59 (1.7)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD KDIGO 3A</td>
<td rowspan="1" colspan="1">11 (13.9)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD KDIGO 3B</td>
<td rowspan="1" colspan="1">9 (11.4)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD KDIGO 4</td>
<td rowspan="1" colspan="1">1 (1.3)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD KDIGO 5</td>
<td rowspan="1" colspan="1">3 (3.8)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">CKD (eGFR &lt;60 mL/min/1.73 m²), <em>n</em> (%)</td>
<td rowspan="1" colspan="1">24 (30.4)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">ESKD on maintenance hemodialysis, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">2 (2.5)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Kidney biopsy, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">2 (2.6)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Liver transplantation, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">6 (7.6)</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="1" colspan="1">First-line treatment with tafamidis, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">50 (63.3)</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="1" colspan="1">First-line treatment with patisiran or inotersen, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">11 (13.9)</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Deaths, <em>n</em> (%)</td>
<td rowspan="1" colspan="1">8 (10.1)</td>
<td rowspan="1" colspan="1">0 (0)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age of death (years), mean ± SD</td>
<td rowspan="1" colspan="1">74.2 ± 11.3</td>
<td rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tb1fn1"><p>Elevated BNP or NT-proBNP: BNP &gt;100 ng/L or NT-proBNP &gt;450 ng/L before 50 years, &gt;900 ng/L between 50 and 75 years, &gt;1800 ng/L after 75 years. Elevated troponin I or troponin T hs : troponin I &gt;0.05 pg/L or troponin T hs &gt;14 ng/L. KDIGO, Kidney Disease: Improving Global Outcomes; NA, not applicable.</p></div></div></section></section><section id="sec3-2"><h3 class="pmc_sec_title">Prevalence of kidney involvement</h3>
<p>Among the 79 symptomatic patients, 13/79 (16.5%) had CKD at the time of diagnosis of ATTRv, 9/56 (16.1%) had significant proteinuria and 1/56 (1.7%) had a nephrotic syndrome.</p>
<p>At the last assessment, 24/79 (30.4%) patients had CKD, 2/79 (2.5%) had developed ESKD and were on maintenance hemodialysis and 12/59 (20.3%) had proteinuria. The two patients who developed ESKD carried the V30M mutation for one and the V122I mutation for the other. Two patients had kidney biopsies, one for a nephrotic syndrome (this case is detailed below) and the other for the discovery of glomerular proteinuria while he was on inotersen. Both kidney biopsies showed glomerular and vascular amyloid deposits (Fig. <a href="#fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">FIGURE 1:</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9394715_sfac118fig1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6346/9394715/eaac8109ef34/sfac118fig1.jpg" loading="lazy" height="691" width="747" alt="FIGURE 1:"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Light microscopy results of kidney biopsy performed in two patients. (<strong>A</strong>) Patient 1: Masson's trichrome staining showed large nodular mesangial glomerular deposits. (<strong>B</strong>) Patient 2: silver staining showed segmental mesangial glomerular and distal vascular deposits (at the vascular pole of the glomeruli). (<strong>C</strong>) Patient 2: Congo-red staining showed glomerular and vascular deposits and confirmed the amyloid nature of these deposits.</p></figcaption></figure><p>Initial symptoms in the 24 CKD patients are summarized in the <a href="#sup1" class="usa-link">Supplementary data, Table S2</a>.</p>
<p>Of the 24 presymptomatic carriers, none had proteinuria or CKD and 0/12 had a urine albumin:creatinine ratio ≥30 mg/g.</p>
<p>Overall, CKD was observed in 24/103 (23.3%) patients of the global cohort. A total of 9.5% of patients &lt;40 years of age, 11.5% between 40 and 60 years, 32.6% between 60 and 80 years and 40.0% &gt;80 years had CKD.</p></section><section id="sec3-3"><h3 class="pmc_sec_title">Factors associated with CKD</h3>
<p>Comparison between the 24 symptomatic patients with CKD and the 55 symptomatic patients without CKD is detailed in Table <a href="#tbl2" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Risk factor of CKD among patients with symptomatic ATTR</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th colspan="7" align="center" rowspan="1">A. Multivariate analysis</th></tr>
<tr>
<th align="left" rowspan="1" colspan="1">Parameters</th>
<th align="left" rowspan="1" colspan="1">Model 1,</th>
<th align="left" rowspan="1" colspan="1">Model 2,</th>
<th align="left" rowspan="1" colspan="1">Model 3,</th>
<th align="left" rowspan="1" colspan="1">Model 4,</th>
<th align="left" rowspan="1" colspan="1">Model 5,</th>
<th align="left" rowspan="1" colspan="1">Model 6,</th>
</tr>
<tr>
<th rowspan="1" colspan="1"></th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="1" colspan="1">Age at amyloidosis onset &gt;60 years</td>
<td rowspan="1" colspan="1">
<strong>4.9 (1.5–20.5)</strong>
</td>
<td rowspan="1" colspan="1">
<strong>4 (1.2–12.7)</strong>
</td>
<td rowspan="1" colspan="1">
<strong>27.6 (3.3–3596)</strong>
</td>
<td rowspan="1" colspan="1">
<strong>4.2 (1.3–13)</strong>
</td>
<td rowspan="1" colspan="1">
<strong>4.1 (1.2–12.9)</strong>
</td>
<td rowspan="1" colspan="1">
<strong>3.1 (1.4–7.9)</strong>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">V122I mutation</td>
<td rowspan="1" colspan="1">
<strong>60.6 (6.2–8334)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<strong>3.1 (1.7–8.2)</strong>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">High BP</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<strong>3.1 (1.1–9.2)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">0.1 (0.9–1.9)</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Proteinuria</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<strong>77 (8.1–10 494)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">
<strong>3.9 (1.4–9.7)</strong>
</td>
</tr>
<tr>
<td rowspan="1" colspan="1">Neuropathy with PND score ≥2</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">2.1 (0.7–6.1)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Cardiac amyloidosis</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1">2.1 (0.7–-6.1)</td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td colspan="4" align="center" rowspan="1">B. Univariate analysis</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<th align="left" rowspan="1" colspan="1">Parameters</th>
<th align="left" rowspan="1" colspan="1">CKD (<em>n</em> = 24)</th>
<th align="left" rowspan="1" colspan="1">No CKD (<em>n</em> = 55)</th>
<th align="left" rowspan="1" colspan="1">OR (95% CI)</th>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1"></th>
<th rowspan="1" colspan="1"></th>
</tr>
<tr>
<td colspan="4" align="center" rowspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Female</td>
<td rowspan="1" colspan="1">7</td>
<td rowspan="1" colspan="1">17</td>
<td rowspan="1" colspan="1">0.9 (0.3–2.6)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age &gt;65 years</td>
<td rowspan="1" colspan="1">17</td>
<td rowspan="1" colspan="1">27</td>
<td rowspan="1" colspan="1">2.5 (0.9–7.0)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age at amyloidosis onset &gt;50 years</td>
<td rowspan="1" colspan="1">20</td>
<td rowspan="1" colspan="1">33</td>
<td rowspan="1" colspan="1">
<strong>3.3 (1.05–11.1)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Age at amyloidosis onset &gt;60 years</td>
<td rowspan="1" colspan="1">19</td>
<td rowspan="1" colspan="1">24</td>
<td rowspan="1" colspan="1">
<strong>4.9 (1.6–15.1)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">V30M mutation</td>
<td rowspan="1" colspan="1">12</td>
<td rowspan="1" colspan="1">30</td>
<td rowspan="1" colspan="1">0.8 (0.3–2.2)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">V122I mutation</td>
<td rowspan="1" colspan="1">8</td>
<td rowspan="1" colspan="1">0</td>
<td rowspan="1" colspan="1">
<strong>57.2 (6.5–7540)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">High BP</td>
<td rowspan="1" colspan="1">12</td>
<td rowspan="1" colspan="1">11</td>
<td rowspan="1" colspan="1">
<strong>4.0 (1.4–11.3)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Type 2 diabetes</td>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">3</td>
<td rowspan="1" colspan="1">2.5 (0.5–13.3)</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Neuropathy with PND score ≥2</td>
<td rowspan="1" colspan="1">13/22</td>
<td rowspan="1" colspan="1">16</td>
<td rowspan="1" colspan="1">
<strong>2.9 (1.1–7.8)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Cardiac amyloidosis</td>
<td rowspan="1" colspan="1">17</td>
<td rowspan="1" colspan="1">25</td>
<td rowspan="1" colspan="1">
<strong>2.9 (1.1–8.1)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
<tr>
<td rowspan="1" colspan="1">Proteinuria</td>
<td rowspan="1" colspan="1">9/17</td>
<td rowspan="1" colspan="1">3/44</td>
<td rowspan="1" colspan="1">
<strong>15.4 (3.4–69.6)</strong>
</td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
<td rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="tb2fn1"><p>ORs were calculated with the Fisher's exact test for the univariate analysis and with a logistic regression model for the multivariate analysis. We used a penalized logistic regression model for the mutation V122I parameter. The presence of high BP, diabetes, neuropathy with a PND score ≥2, cardiac amyloidosis and proteinuria was considered at the time of CKD onset in patients with CKD or at the last assessment in patients without CKD.</p></div></div></section><p>In univariate analysis, late onset of symptoms, i.e. after 50 years {OR 3.3 [95% confidence interval (CI) 1.05–11.1)]} and <em>a fortiori</em> after 60 years [OR 4.9 (95% CI 1.6–15.1)] were associated with CKD. High BP [4.0 (95% CI 1.4–11.3)], proteinuria [OR 15.4 (95% CI 3.4–69.6)], presence of cardiac involvement [OR 2.9 (95% CI 1.1–8.1)] and presence of severe neuropathy with a PND score ≥2 [OR 2.9 (95% CI 1.1–7.8)] were also associated with CKD. The V122I mutation was strongly associated with CKD [OR 57.2 (95% CI 6.5–7540)] and not the V30M mutation. Age &gt;65 years and diabetes were not significantly associated with CKD in this population, but only six patients were diabetic (Table <a href="#tbl2" class="usa-link">2A</a>).</p>
<p>In multivariate analysis adjusted for age of onset &gt;60 years, high BP [OR 3.1 (95% CI 1.1–9.2)], the V122I mutation [OR 60.6 (95% CI 6.2–8334)] and proteinuria [OR 77 (95% CI 8.1–10494)] were strongly associated with CKD. In a final model taking into account age of onset &gt;60 years, high BP, the V122I mutation and proteinuria, these factors remained statistically associated with CKD, except for high BP (Table <a href="#tbl2" class="usa-link">2B</a>).</p></section><section id="sec3-4"><h3 class="pmc_sec_title">Survival without CKD</h3>
<p>CKD-free survival in the 79 symptomatic patients, from birth to the last assessment of kidney function, is reported in Fig. <a href="#fig2" class="usa-link">2</a>A. Median CKD-free survival was 81.0 years (interquartile range 77.1–85.0). The average age of onset of CKD was 69.3 ± 13.0 years. Among the 24 patients with CKD, the mean duration between the onset of symptoms of amyloidosis and CKD was 1.9 ± 3.7 years. CKD-free survival was significantly lower in the symptomatic patients with the V122I mutation (logrank test; <em>P</em> = .006) than in patients with other mutations (Fig. <a href="#fig2" class="usa-link">2</a>B, C).</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">FIGURE 2:</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6346/9394715/4bb3f92a2556/sfac118fig2.jpg" loading="lazy" height="1452" width="622" alt="FIGURE 2:"></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Survival without CKD (eGFR &lt;60 mL/min/1.73 m<sup>2</sup>), from birth to the last assessment of kidney function: (<strong>A</strong>) in the 79 symptomatic patients from the present cohort, (<strong>B</strong>) V30M mutation versus other mutations and (<strong>C</strong>) V122I mutation versus other mutations (logrank test; <em>P</em> = .006).</p></figcaption></figure></section><section id="sec3-5"><h3 class="pmc_sec_title">Nephrotic syndrome as an initial manifestation of ATTRv amyloidosis</h3>
<p>One 38-year-old female carrying the V30M mutation, who had remained asymptomatic until then, presented in June 2020 with a nephrotic syndrome (serum albumin 23 g/L, UPCR 3.5 g/g, lower limb edema) with normal kidney function. Her family history is presented in Fig. <a href="#fig3" class="usa-link">3</a>A. Kidney biopsy showed massive Congo red–positive amyloid deposits that showed apple-green birefringence under polarized light (Fig. <a href="#fig1" class="usa-link">1A</a>). Anti-TTR antibody fixation was not detected by immunohistochemistry, but repeat genetic analyses confirmed the exclusive heterozygous mutation of V30M (with no other amyloid-related genetic mutation) and proteomic analysis by mass spectrometry of micro dissected glomeruli confirmed the presence of TTR in the amyloid deposits. She had no cardiac involvement of ATTRv (normal MRI) and a stage 1 neuropathy (discrete paresthesia, normal EMG, altered Sudoscan). She was treated with angiotensin-converting enzyme inhibitors and diuretics without remission of the nephrotic syndrome after 5 months. In November 2020, a treatment with patisiran [small interfering RNA (siRNA)] was initiated, with progressive remission of the nephrotic syndrome (Fig. <a href="#fig3" class="usa-link">3B</a>). Diuretics were discontinued in April 2021. Kidney function remained normal.</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">FIGURE 3:</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=9394715_sfac118fig3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6346/9394715/d3f259f380d0/sfac118fig3.jpg" loading="lazy" height="336" width="799" alt="FIGURE 3:"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>
<strong>(A)</strong> Family history of the patient with predominant kidney involvement of ATTR. <strong>(B)</strong> Evolution of serum albumin and urine protein:creatinine ratio in the patient with predominant kidney involvement of ATTR.</p></figcaption></figure></section></section><section id="sec4"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>In this French cohort study, we showed a prevalence of CKD of 23% in all patients carrying a <em>TTR</em> mutation and of 30% among patients with symptomatic ATTRv. CKD was globally a late event in life (median CKD-free survival was estimated at 81 years) but could be encountered in young patients and could develop rapidly after the diagnosis of ATTRv. Not all <em>TTR</em> mutations were equal in terms of kidney involvement of ATTRv, and the V122I mutation seemed particularly at risk of CKD. We also describe here the first case of a young patient with a kidney-predominant involvement of ATTRv for whom treatment with TTR siRNA (patisiran) resulted in remission of the nephrotic syndrome.</p>
<p>Data on kidney function impairment in ATTRv are highly variable in the literature, with various definitions of CKD. The prevalence of CKD ranges from 10% to 50% of patients with symptomatic ATTRv in different cohorts [<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib16" class="usa-link" aria-describedby="bib16">16–19</a>]. The three largest studies reporting kidney involvement in ATTRv are from Italy, the USA and Portugal. Ferraro <em>et al</em>. [<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>] reported a prevalence of CKD of 15% in a cohort of 46 patients with ATTRv (mostly with the F64L and V30M mutations). Gertz <em>et al</em>. [<a href="#bib18" class="usa-link" aria-describedby="bib18">18</a>] described 52 ATTRv patients from the Mayo Clinic carrying diverse mutations: 16% had CKD (without a precise definition of eGFR threshold) and 2% had ESKD. Lobato <em>et al</em>. [<a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>] observed that among 403 symptomatic patients with the V30M mutation followed in three districts in Portugal, 36% had CKD (defined by a serum creatinine &gt;106 µmol/L) and 11% had ESKD. Our study showed the same range of prevalence of CKD but a lower prevalence of ESKD than in Portugal. However, the phenotypic variability in ATTRv amyloidosis reflects the crucial role of genetic and environmental parameters.</p>
<p>Factors associated with CKD in the present study are both general, as described in the general population, and specific to ATTRv amyloidosis. The late onset of amyloid symptoms (&gt;60 years of age) is strongly linked to CKD, as has been previously described by Lobato <em>et al</em>. [<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a>]. Whether this association is coincidental, related to a survivorship bias (older patients being at higher risk of CKD), related to a peculiar susceptibility of older kidneys to amyloid deposition damage or related to a peculiar pattern of amyloid deposition in late-onset forms cannot be concluded here. As an age of symptom onset &gt;60 years appears to be central to the assessment of CKD risk, we included this parameter in the multivariate analysis models. Severity of neuropathy was associated with CKD in univariate analysis, which has already been suggested in one study [<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a>], as well as cardiac involvement. However, these parameters were no longer significantly associated with CKD after adjustment for age of symptom onset &gt;60 years.</p>
<p>Importantly, this is the first study to suggest that the V122I mutation could be an important risk factor for CKD, as shown by multivariate and survival curve analyses. This mutation, which is encountered in 3.5% of African Americans, is associated with a cardiac predominant phenotype [<a href="#bib20" class="usa-link" aria-describedby="bib20">20–22</a>], which could be a confounding factor. Moreover, other risk factors for CKD among the V122I mutation carriers, such as sickle cell trait [<a href="#bib23" class="usa-link" aria-describedby="bib23">23</a>] or APOL1 gene variants [<a href="#bib24" class="usa-link" aria-describedby="bib24">24</a>], were not investigated and could be additional confounding factors.</p>
<p>The involvement of ATTRv per se in the development of CKD in this population remains to be determined. Proteinuria appears to be the first step in the natural history of ATTRv nephropathy. A prospective study of 52 patients, comprising 22 presymptomatic carriers, showed that the presence of microalbuminuria was associated with a risk ratio of 4.8 of developing neuropathy in presymptomatic carriers and with the risk of CKD in the overall cohort [<a href="#bib25" class="usa-link" aria-describedby="bib25">25</a>]. Similarly, a series of 62 patients with the V30M mutation on maintenance haemodialysis, which excluded liver transplant recipients, showed that 90% had proteinuria before ESKD [<a href="#bib26" class="usa-link" aria-describedby="bib26">26</a>]. In the present study, proteinuria was also strongly associated with CKD. The two patients who had a kidney biopsy displayed amyloid deposits in the glomeruli, vessels and tubulointerstitium. Nevertheless, proteinuria is not specific to renal amyloidosis and could be related to other kidney lesions. A series of renal biopsies in the literature have shown the presence of amyloid deposits that can affect all compartments of the kidney, even in patients with CKD but without proteinuria [<a href="#bib27" class="usa-link" aria-describedby="bib27">27–29</a>].</p>
<p>However, amyloidosis does seem to be responsible for the renal damage in some patients; here we describe the case of a V30M patient with predominant kidney amyloidosis, with nephrotic syndrome and very mild neurological involvement, who was treated with patisiran with a remission of the nephrotic syndrome. This is a new dimension of siRNA, whose effectiveness has been established so far in the evolution of the neuropathy severity score [<a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>]. Several case studies have shown a marked decrease in proteinuria with tafamidis, as well as a case of remission of a nephrotic syndrome within 1 year [<a href="#bib30" class="usa-link" aria-describedby="bib30">30–32</a>]. This suggests some degree of reversibility of ATTRv nephropathy when the process of amyloid fibrils deposition is blocked, which implies a dynamic turnover in the kidney with a clearance of deposits, as in abdominal fat [<a href="#bib33" class="usa-link" aria-describedby="bib33">33</a>].</p>
<p>Our study has several limitations beyond its retrospective design. A microalbuminuria assay was not available for all patients or presymptomatic carriers from the present cohort and proteinuria was measured in only 79% of patients. Thus the prevalence of microalbuminuria may have been underestimated. Factors associated with CKD were collected retrospectively. We did not study family aggregation of kidney involvement. But this study also has strengths. It is one of the largest cohorts evaluating kidney involvement in patients with ATTRv and comprises patients with various <em>TTR</em> mutations (only 54% of patients carried the V30M mutation). Because the exact timing of amyloid deposits is largely unknown, and the diagnosis of amyloidosis can be delayed, we decided to study CKD-free survival from birth and describe the factors associated with CKD in this population.</p>
<p>In conclusion, CKD affected almost one-third of patients with symptomatic ATTRv, with a mean age at CKD onset of 69 years, and could lead to ESKD. Proteinuria, late onset (&gt;60 years) of amyloidosis symptoms and the V122I mutation were associated with CKD in this population. Predominant kidney ATTRv with nephrotic syndrome was observed in one patient who responded to gene silencing therapy. ATTRv is often diagnosed with delay in nonendemic regions such as France [<a href="#bib34" class="usa-link" aria-describedby="bib34">34</a>]. We recommend a more systematic screening of proteinuria and renal function in all ATTRv patients. We do not recommend performing a kidney biopsy systematically to document kidney involvement in ATTRv amyloidosis, but we believe that kidney biopsy can be valuable to rule out differential diagnoses in patients with nephrotic syndrome or rapidly decreasing kidney function. Greater awareness of nephrologists for this rare disease could allow earlier diagnosis and access to therapy for symptomatic patients.</p></section><section id="sec20"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="sup1"><div class="caption p"><span>sfac118_Supplemental_File</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9394715/bin/sfac118_supplemental_file.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (16.5KB, docx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">ACKNOWLEDGEMENTS</h2>
<p>We are grateful to Dr Luisa Lobato, in Porto, who provided clinical information on the family history and previous explorations of the patient with predominant kidney ATTRv. We thank Anne Guiochon-Mantel and Sophie Valleix, who performed genetic analyses and Dr Magali Colombat, who performed the proteomic analysis of microdissected glomeruli in this patient. We thank the medical and nursing teams of the hospital of la Timone and of Carémeau.</p></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Justine Solignac, 
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p>
<p>Emilien Delmont, 
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p>
<p>Etienne Fortanier, 
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p>
<p>Shahram Attarian, 
Centre de Référence des Maladies Neuromusculaires et SLA, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p>
<p>Julien Mancini, 
SESSTIM, INSERM Université Aix Marseille, Sciences Economiques et Sociales de la Santé and Traitement de l'Information Médicale, Marseille, France.</p>
<p>Laurent Daniel, 
Service d'Anatomo-cyto-pathologie, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p>
<p>Ioana Ion, 
Service de Neurologie Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France.</p>
<p>Jean-Etienne Ricci, 
Service de Cardiologie, Hôpital Carémeau, Assistance Publique–Hôpitaux de Nîmes, Nîmes, France.</p>
<p>Thomas Robert, 
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France; 
MMG, Bioinformatics and Genetics, Aix-Marseille Université, Marseille, France.</p>
<p>Gilbert Habib, 
Service de Cardiologie, Insuffisance Cardiaque, Hôpital de la Timone, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p>
<p>Olivier Moranne, 
Service Néphrologie-Dialyses-Aphérèses, Hôpital Universitaire de Nîmes, CHU Caremeau, Nîmes, France; 
IDESP, INSERM Université de Montpellier, Montpellier, France.</p>
<p>Noémie Jourde-Chiche, 
Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France.</p></section><section id="sec5"><h2 class="pmc_sec_title">CONFLICT OF INTEREST STATEMENT</h2>
<p>None declared.</p></section><section id="ref1" class="ref-list"><h2 class="pmc_sec_title">REFERENCES</h2>
<section id="ref1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>
Lobato L, Rocha A. Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol 2012; 7: 1337–1346</cite> [<a href="https://doi.org/10.2215/CJN.08720811" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22537653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Transthyretin%20amyloidosis%20and%20the%20kidney&amp;volume=7&amp;publication_year=2012&amp;pages=1337-1346&amp;pmid=22537653&amp;doi=10.2215/CJN.08720811&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>
Schmidt M, Wiese S, Adak Vet al. 
Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat Commun 2019; 10: 5008.</cite> [<a href="https://doi.org/10.1038/s41467-019-13038-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6825171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31676763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Cryo-EM%20structure%20of%20a%20transthyretin-derived%20amyloid%20fibril%20from%20a%20patient%20with%20hereditary%20ATTR%20amyloidosis&amp;volume=10&amp;publication_year=2019&amp;pages=5008&amp;pmid=31676763&amp;doi=10.1038/s41467-019-13038-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>
Conceição I, González-Duarte A, Obici Let al. 
“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst 2016; 21: 5–9</cite> [<a href="https://doi.org/10.1111/jns.12153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4788142/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26663427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Peripher%20Nerv%20Syst&amp;title=%E2%80%9CRed-flag%E2%80%9D%20symptom%20clusters%20in%20transthyretin%20familial%20amyloid%20polyneuropathy&amp;volume=21&amp;publication_year=2016&amp;pages=5-9&amp;pmid=26663427&amp;doi=10.1111/jns.12153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>
Parman Y, Adams D, Obici Let al. 
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP. Curr Opin Neurol 2016; 29: S3–S13</cite> [<a href="https://doi.org/10.1097/WCO.0000000000000288" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4739317/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26734951/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Neurol&amp;title=Sixty%20years%20of%20transthyretin%20familial%20amyloid%20polyneuropathy%20(TTR-FAP)%20in%20Europe:%20where%20are%20we%20now?%20A%20European%20network%20approach%20to%20defining%20the%20epidemiology%20and%20management%20patterns%20for%20TTR-FAP&amp;volume=29&amp;publication_year=2016&amp;pages=S3-S13&amp;pmid=26734951&amp;doi=10.1097/WCO.0000000000000288&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>
Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA 2020; 324: 79–89</cite> [<a href="https://doi.org/10.1001/jama.2020.5493" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32633805/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Systemic%20amyloidosis%20recognition,%20prognosis,%20and%20therapy:%20a%20systematic%20review&amp;volume=324&amp;publication_year=2020&amp;pages=79-89&amp;pmid=32633805&amp;doi=10.1001/jama.2020.5493&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>
Coelho T, Maia LF, Martins da Silva Aet al. 
Tafamidis for transthyretin familial amyloid polyneuropathy. Neurology 2012; 79: 785–792</cite> [<a href="https://doi.org/10.1212/WNL.0b013e3182661eb1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4098875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22843282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Tafamidis%20for%20transthyretin%20familial%20amyloid%20polyneuropathy&amp;volume=79&amp;publication_year=2012&amp;pages=785-792&amp;pmid=22843282&amp;doi=10.1212/WNL.0b013e3182661eb1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>
Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976; 590: 1–64</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1064291/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Med%20Scand%20Suppl&amp;title=Familial%20amyloidosis%20with%20polyneuropathy.%20A%20clinical%20study%20based%20on%20patients%20living%20in%20northern%20Sweden&amp;volume=590&amp;publication_year=1976&amp;pages=1-64&amp;pmid=1064291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>
Adams D, Gonzalez-Duarte A, O'riordan WDet al. 
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 2018; 379: 11–21</cite> [<a href="https://doi.org/10.1056/NEJMoa1716153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Patisiran,%20an%20RNAi%20therapeutic,%20for%20hereditary%20transthyretin%20amyloidosis&amp;volume=379&amp;publication_year=2018&amp;pages=11-21&amp;pmid=29972753&amp;doi=10.1056/NEJMoa1716153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>
Benson MD, Waddington-Cruz M, Berk JLet al. 
Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 2018; 379: 22–31</cite> [<a href="https://doi.org/10.1056/NEJMoa1716793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12611561/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29972757/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Inotersen%20treatment%20for%20patients%20with%20hereditary%20transthyretin%20amyloidosis&amp;volume=379&amp;publication_year=2018&amp;pages=22-31&amp;pmid=29972757&amp;doi=10.1056/NEJMoa1716793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>
Gillmore JD, Gane Ed, Taubel Jet al. 
CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med 2021; 385: 493–502</cite> [<a href="https://doi.org/10.1056/NEJMoa2107454" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34215024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=CRISPR-Cas9%20in%20vivo%20gene%20editing%20for%20transthyretin%20amyloidosis&amp;volume=385&amp;publication_year=2021&amp;pages=493-502&amp;pmid=34215024&amp;doi=10.1056/NEJMoa2107454&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>
Mariani L-L, Lozeron P, Théaudin Met al. 
Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France. Ann Neurol 2015; 78: 901–916</cite> [<a href="https://doi.org/10.1002/ana.24519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4738459/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26369527/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Neurol&amp;title=Genotype%E2%80%93phenotype%20correlation%20and%20course%20of%20transthyretin%20familial%20amyloid%20polyneuropathies%20in%20France&amp;volume=78&amp;publication_year=2015&amp;pages=901-916&amp;pmid=26369527&amp;doi=10.1002/ana.24519&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>
Coelho T, Maurer MS, Suhr OB. THAOS – the Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin 2013; 29: 63–76</cite> [<a href="https://doi.org/10.1185/03007995.2012.754348" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23193944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Med%20Res%20Opin&amp;title=THAOS%20%E2%80%93%20the%20Transthyretin%20Amyloidosis%20Outcomes%20Survey:%20initial%20report%20on%20clinical%20manifestations%20in%20patients%20with%20hereditary%20and%20wild-type%20transthyretin%20amyloidosis&amp;volume=29&amp;publication_year=2013&amp;pages=63-76&amp;pmid=23193944&amp;doi=10.1185/03007995.2012.754348&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>
Ferraro PM, D'ambrosio V, Di Paolantonio Aet al. 
Renal involvement in hereditary transthyretin amyloidosis: an Italian single-centre experience. Brain Sci 2021; 11: 980.</cite> [<a href="https://doi.org/10.3390/brainsci11080980" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8394946/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34439599/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain%20Sci&amp;title=Renal%20involvement%20in%20hereditary%20transthyretin%20amyloidosis:%20an%20Italian%20single-centre%20experience&amp;volume=11&amp;publication_year=2021&amp;pages=980&amp;pmid=34439599&amp;doi=10.3390/brainsci11080980&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>
Gregg LP, Richardson PA, Akeroyd Jet al. 
Effects of the 2021 CKD-EPI creatinine eGFR equation among a national US veteran cohort. Clin J Am Soc Nephrol 2022; 17: 283–285</cite> [<a href="https://doi.org/10.2215/CJN.10000721" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8823927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34799356/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Effects%20of%20the%202021%20CKD-EPI%20creatinine%20eGFR%20equation%20among%20a%20national%20US%20veteran%20cohort&amp;volume=17&amp;publication_year=2022&amp;pages=283-285&amp;pmid=34799356&amp;doi=10.2215/CJN.10000721&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>
Hanewinckel R, Ikram MA, Van Doorn PA. Assessment scales for the diagnosis of polyneuropathy. J Peripher Nerv Syst 2016; 21: 61–73</cite> [<a href="https://doi.org/10.1111/jns.12170" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26968746/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Peripher%20Nerv%20Syst&amp;title=Assessment%20scales%20for%20the%20diagnosis%20of%20polyneuropathy&amp;volume=21&amp;publication_year=2016&amp;pages=61-73&amp;pmid=26968746&amp;doi=10.1111/jns.12170&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>
Steen L, Wahlin A, Bjerle Pet al. 
Renal function in familial amyloidosis with polyneuropathy. Acta Med Scand 2009; 212: 233–236</cite> [<a href="https://doi.org/10.1111/j.0954-6820.1982.tb03205.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6959471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Med%20Scand&amp;title=Renal%20function%20in%20familial%20amyloidosis%20with%20polyneuropathy&amp;volume=212&amp;publication_year=2009&amp;pages=233-236&amp;pmid=6959471&amp;doi=10.1111/j.0954-6820.1982.tb03205.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>
Ikeda S-I, Hanyu N, Hongo Met al. 
Hereditary generalized amyloidosis with polyneuropathy: clinicopathological study of 65 Japanese patients. Brain 1987; 110: 315–337</cite> [<a href="https://doi.org/10.1093/brain/110.2.315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3032328/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Hereditary%20generalized%20amyloidosis%20with%20polyneuropathy:%20clinicopathological%20study%20of%2065%20Japanese%20patients&amp;volume=110&amp;publication_year=1987&amp;pages=315-337&amp;pmid=3032328&amp;doi=10.1093/brain/110.2.315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>
Gertz MA, Kyle RA, Thibodeau SN. Familial amyloidosis: a study of 52 North American-born patients examined during a 30-year period. Mayo Clin Proc 1992; 67: 428–440</cite> [<a href="https://doi.org/10.1016/s0025-6196(12)60388-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1405768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin%20Proc&amp;title=Familial%20amyloidosis:%20a%20study%20of%2052%20North%20American-born%20patients%20examined%20during%20a%2030-year%20period&amp;volume=67&amp;publication_year=1992&amp;pages=428-440&amp;pmid=1405768&amp;doi=10.1016/s0025-6196(12)60388-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<span class="label">19.</span><cite>
Lobato L. A Nefropatia na Polineuropatia Amiloidotica Familiar de Tipo Portugues (TTR V30M). Porto: Instituto de Ciencias Biome dicas Abel Salazar, 2004</cite> [<a href="https://scholar.google.com/scholar_lookup?title=A%20Nefropatia%20na%20Polineuropatia%20Amiloidotica%20Familiar%20de%20Tipo%20Portugues%20(TTR%20V30M)&amp;publication_year=2004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>
Maurer MS, Hanna M, Grogan Met al. 
Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey). J Am Coll Cardiol 2016; 68: 161–172</cite> [<a href="https://doi.org/10.1016/j.jacc.2016.03.596" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4940135/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27386769/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Coll%20Cardiol&amp;title=Genotype%20and%20phenotype%20of%20transthyretin%20cardiac%20amyloidosis:%20THAOS%20(Transthyretin%20Amyloid%20Outcome%20Survey)&amp;volume=68&amp;publication_year=2016&amp;pages=161-172&amp;pmid=27386769&amp;doi=10.1016/j.jacc.2016.03.596&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>
Buxbaum JN, Ruberg FL. Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans. Genet Med 2017; 19: 733–742</cite> [<a href="https://doi.org/10.1038/gim.2016.200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5509498/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28102864/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet%20Med&amp;title=Transthyretin%20V122I%20(pV142I)*%20cardiac%20amyloidosis:%20an%20age-dependent%20autosomal%20dominant%20cardiomyopathy%20too%20common%20to%20be%20overlooked%20as%20a%20cause%20of%20significant%20heart%20disease%20in%20elderly%20African%20Americans&amp;volume=19&amp;publication_year=2017&amp;pages=733-742&amp;pmid=28102864&amp;doi=10.1038/gim.2016.200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<span class="label">22.</span><cite>
Jacobson DR, Alexander AA, Tagoe Cet al. 
Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans. Amyloid 2015; 22: 171–174</cite> [<a href="https://doi.org/10.3109/13506129.2015.1051219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26123279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Prevalence%20of%20the%20amyloidogenic%20transthyretin%20(TTR)%20V122I%20allele%20in%2014%E2%80%89333%20African-Americans&amp;volume=22&amp;publication_year=2015&amp;pages=171-174&amp;pmid=26123279&amp;doi=10.3109/13506129.2015.1051219&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<span class="label">23.</span><cite>
Naik RP, Irvin MR, Judd Set al. 
Sickle cell trait and the risk of ESRD in Blacks. J Am Soc Nephrol 2017; 28: 2180–2187</cite> [<a href="https://doi.org/10.1681/ASN.2016101086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5491293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28280138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Soc%20Nephrol&amp;title=Sickle%20cell%20trait%20and%20the%20risk%20of%20ESRD%20in%20Blacks&amp;volume=28&amp;publication_year=2017&amp;pages=2180-2187&amp;pmid=28280138&amp;doi=10.1681/ASN.2016101086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<span class="label">24.</span><cite>
Freedman BI, Limou S, Ma Let al. 
APOL1-associated nephropathy: a key contributor to racial disparities in CKD. Am J Kidney Dis 2018; 72: S8–S16</cite> [<a href="https://doi.org/10.1053/j.ajkd.2018.06.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6200346/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30343724/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=APOL1-associated%20nephropathy:%20a%20key%20contributor%20to%20racial%20disparities%20in%20CKD&amp;volume=72&amp;publication_year=2018&amp;pages=S8-S16&amp;pmid=30343724&amp;doi=10.1053/j.ajkd.2018.06.020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib25">
<span class="label">25.</span><cite>
Lobato L, Beirão I, Silva Met al. 
Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003; 18: 532–538</cite> [<a href="https://doi.org/10.1093/ndt/18.3.532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12584275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Familial%20ATTR%20amyloidosis:%20microalbuminuria%20as%20a%20predictor%20of%20symptomatic%20disease%20and%20clinical%20nephropathy&amp;volume=18&amp;publication_year=2003&amp;pages=532-538&amp;pmid=12584275&amp;doi=10.1093/ndt/18.3.532&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib26">
<span class="label">26.</span><cite>
Lobato L, Beirão I, Silva Met al. 
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid 2004; 11: 27–37</cite> [<a href="https://doi.org/10.1080/13506120410001673884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15185496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=End-stage%20renal%20disease%20and%20dialysis%20in%20hereditary%20amyloidosis%20TTR%20V30M:%20presentation,%20survival%20and%20prognostic%20factors&amp;volume=11&amp;publication_year=2004&amp;pages=27-37&amp;pmid=15185496&amp;doi=10.1080/13506120410001673884&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib27">
<span class="label">27.</span><cite>
Lobato L, Beirao I, Guimaraes Smet al. 
Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Am J Kidney Dis 1998; 7: 940–946</cite> [<a href="https://doi.org/10.1053/ajkd.1998.v31.pm9631837" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9631837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Kidney%20Dis&amp;title=Familial%20amyloid%20polyneuropathy%20type%20I%20(Portuguese):%20distribution%20and%20characterization%20of%20renal%20amyloid%20deposits&amp;volume=7&amp;publication_year=1998&amp;pages=940-946&amp;pmid=9631837&amp;doi=10.1053/ajkd.1998.v31.pm9631837&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib28">
<span class="label">28.</span><cite>
Snanoudj R, Durrbach A, Gauthier Eet al. 
Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrol Dial Transplant 2004; 19: 1779–1785</cite> [<a href="https://doi.org/10.1093/ndt/gfh063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15150345/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephrol%20Dial%20Transplant&amp;title=Changes%20in%20renal%20function%20in%20patients%20with%20familial%20amyloid%20polyneuropathy%20treated%20with%20orthotopic%20liver%20transplantation&amp;volume=19&amp;publication_year=2004&amp;pages=1779-1785&amp;pmid=15150345&amp;doi=10.1093/ndt/gfh063&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib29">
<span class="label">29.</span><cite>
Oguchi K, Takei Yo-I, Ikeda S-I. Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients. Amyloid 2006; 13: 99–107</cite> [<a href="https://doi.org/10.1080/13506120600722662" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16911964/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Value%20of%20renal%20biopsy%20in%20the%20prognosis%20of%20liver%20transplantation%20in%20familial%20amyloid%20polyneuropathy%20ATTR%20Val30Met%20patients&amp;volume=13&amp;publication_year=2006&amp;pages=99-107&amp;pmid=16911964&amp;doi=10.1080/13506120600722662&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib30">
<span class="label">30.</span><cite>
Rocha A, Silva A, Cardoso Met al. 
Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule. Amyloid 2017; 24: 81–82</cite> [<a href="https://doi.org/10.1080/13506129.2016.1277697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28434370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Transthyretin%20(ATTR)%20amyloidosis%20nephropathy:%20lessons%20from%20a%20TTR%20stabilizer%20molecule&amp;volume=24&amp;publication_year=2017&amp;pages=81-82&amp;pmid=28434370&amp;doi=10.1080/13506129.2016.1277697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib31">
<span class="label">31.</span><cite>
Ferrer-Nadal A, Ripoll T, Uson Met al. 
Significant reduction in proteinuria after treatment with tafamidis. Amyloid 2019; 26: 67–68</cite> [<a href="https://doi.org/10.1080/13506129.2019.1583186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31343359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Significant%20reduction%20in%20proteinuria%20after%20treatment%20with%20tafamidis&amp;volume=26&amp;publication_year=2019&amp;pages=67-68&amp;pmid=31343359&amp;doi=10.1080/13506129.2019.1583186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib32">
<span class="label">32.</span><cite>
Ikeda S-I, Hineno A, Ichikawa Tet al. 
Tafamidis dramatically improved severe proteinuria in a patient with TTR V30M hereditary ATTR amyloidosis. Amyloid 2019; 26: 99–100</cite> [<a href="https://doi.org/10.1080/13506129.2019.1600497" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31090446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Tafamidis%20dramatically%20improved%20severe%20proteinuria%20in%20a%20patient%20with%20TTR%20V30M%20hereditary%20ATTR%20amyloidosis&amp;volume=26&amp;publication_year=2019&amp;pages=99-100&amp;pmid=31090446&amp;doi=10.1080/13506129.2019.1600497&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib33">
<span class="label">33.</span><cite>
Tsuchiya A, Yazaki M, Kametani Fet al. 
Marked regression of abdominal fat amyloid in patients with familial amyloid polyneuropathy during long-term follow-up after liver transplantation. Liver Transpl 2008; 14: 563–570</cite> [<a href="https://doi.org/10.1002/lt.21395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18383093/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20Transpl&amp;title=Marked%20regression%20of%20abdominal%20fat%20amyloid%20in%20patients%20with%20familial%20amyloid%20polyneuropathy%20during%20long-term%20follow-up%20after%20liver%20transplantation&amp;volume=14&amp;publication_year=2008&amp;pages=563-570&amp;pmid=18383093&amp;doi=10.1002/lt.21395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib34">
<span class="label">34.</span><cite>
Adams D, Lozeron P, Theaudin Met al. 
Regional difference and similarity of familial amyloidosis with polyneuropathy in France. Amyloid 2012; 19: 61–64</cite> [<a href="https://doi.org/10.3109/13506129.2012.685665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22620968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid&amp;title=Regional%20difference%20and%20similarity%20of%20familial%20amyloidosis%20with%20polyneuropathy%20in%20France&amp;volume=19&amp;publication_year=2012&amp;pages=61-64&amp;pmid=22620968&amp;doi=10.3109/13506129.2012.685665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>sfac118_Supplemental_File</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/9394715/bin/sfac118_supplemental_file.docx" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (16.5KB, docx) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Clinical Kidney Journal are provided here courtesy of <strong>Oxford University Press</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1093/ckj/sfac118"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/sfac118.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (664.4 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/9394715/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/9394715/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC9394715%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC9394715/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC9394715/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC9394715/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/36003663/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC9394715/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/36003663/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC9394715/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/9394715/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="psXpVJY55u7xx97mRF890p2OxZvZLVTZqbK6oumh2Qm3RCqH5TdPO3uoiNLzovAD">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
